Impact of female sex on outcome after percutaneous coronary intervention

American Heart Journal

Volumn 148, Issue 6, 2004, Pages 998-1002

  Chiu, John H ^a   Bhatt, Deepak L ^a   Ziada, Khaled M ^a   Chew, Derek P ^b   Whitlow, Patrick L ^a   Michael Lincoff, A ^a   Ellis, Stephen G ^a   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENDER; HEART INFARCTION; HEMATOMA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVASCULARIZATION; SEX DIFFERENCE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POSTOPERATIVE HEMORRHAGE; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; TREATMENT OUTCOME;

EID: 10644289283     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.05.045     Document Type: Article

References (27)

1. Heart Disease and Stroke Statistics - 2003 Update. 2002;American Heart Association, Dallas (Tex)
2. Women and Cardiovascular Diseases. 2003;American Heart Association, Dallas (Tex)
3. Weintraub W.S., Wenger N.K., Kosinski A.S., et al. Percutaneous transluminal coronary angioplasty in women compared with men. J Am Coll Cardiol. 24:1994;81-90
4. Ellis S.G., Roubin G.S., King S.B. III, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures. J Am Coll Cardiol. 11:1988;211-216
5. Kelsey S.F., James M., Holubkov A.L., et al. Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 87:1993;720-727
6. Cowley M.J., Mullin S.M., Kelsey S.F., et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation. 71:1985;90-97
7. Ayanian J.Z., Epstein A.M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 325:1991;221-225
8. Steingart R.M., Packer M., Hamm P., et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med. 325:1991;226-230
9. Weitzman S., Cooper L., Chambless L., et al. Gender, racial, and geographic differences in the performance of cardiac diagnostic and therapeutic procedures for hospitalized acute myocardial infarction in four states. Am J Cardiol. 79:1997;722-726
10. Peterson E.D., Lansky A.J., Kramer J., et al. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol. 88:2001;359-364
11. Arnold A.M., Mick M.J., Piedmonte M.R., et al. Gender differences for coronary angioplasty. Am J Cardiol. 74:1994;18-21
12. Malenka D.J., Wennberg D.E., Quinton H.A., et al. Gender-related changes in the practice and outcomes of percutaneous coronary interventions in Northern New England from 1994 to 1999. J Am Coll Cardiol. 40:2002;2092-2101
13. Alfonso F., Hernandez R., Banuelos C., et al. Initial results and long-term clinical and angiographic outcome of coronary stenting in women. Am J Cardiol. 86:2000;1380-1383. A5
14. Robertson T., Kennard E.D., Mehta S., et al. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. Am J Cardiol. 80:1997;26K-39K
15. Jacobs A.K., Kelsey S.F., Yeh W., et al. Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. Am J Cardiol. 80:1997;979-984
16. Jacobs A.K., Kelsey S.F., Brooks M.M., et al. Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI). Circulation. 98:1998;1279-1285
17. Glaser R., Herrmann H.C., Murphy S.A., et al. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 288:2002;3124-3129
18. Azar R.R., Waters D.D., McKay R.G., et al. Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction. Am J Cardiol. 85:2000;675-679
19. Antoniucci D., Valenti R., Moschi G., et al. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol. 87:2001;289-293
20. Mehilli J., Kastrati A., Dirschinger J., et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA. 287:2002;210-215
21. Mehilli J., Kastrati A., Dirschinger J., et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA. 284:2000;1799-1805
22. Wallentin L., Lagerqvist B., Husted S., et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 356:2000;9-16
23. Watanabe C.T., Maynard C., Ritchie J.L. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol. 88:2001;848-852
24. Cho L., Topol E.J., Balog C., et al. Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent. J Am Coll Cardiol. 36:2000;381-386
25. Fernandes L.S., Tcheng J.E., O'Shea J.C., et al. Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study. J Am Coll Cardiol. 40:2002;1085-1091
26. Cho L., Marso S.P., Bhatt D.L., et al. Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial. J Womens Health Gend Based Med. 9:2000;741-746
27. Iakovou I., Dangas G., Mehran R., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 15:2003;18-22